Stimulants & ADHD Medications at AACAP Annual Meeting 2026
34 sessions on stimulants & adhd medications · October 26–31, 2026, Atlanta, GA. Compare stimulants & adhd medications at other meetings →
Monday, October 26
13:30–15:30 · Lecture · Clinical Perspectives
Managing Inattention in ADHD, Autism, and Intellectual Developmental Disorder
Addresses managing inattention across ADHD, autism, and intellectual developmental disorder.
ADHD · Autism & Neurodevelopmental Disorders · Child & Adolescent
Wednesday, October 28
11:00–13:00 · Symposium · Clinical Perspectives
Stimulant Use Disorders in Youth and Young Adults: Innovations in Data, Identification, and Treatment
Sara J. Polley · Gerald Busch · Niranjan S. Karnik · Laura A. Markley
Covers new data, identification approaches, and treatment options for stimulant use disorders in adolescents and young adults.
12:00–14:00 · Lecture
Updates in Stimulant Pharmacotherapy for ADHD: Recent Evidence and Clinical Considerations in Special Populations
Reviews recent evidence on stimulant treatment for ADHD and considerations for special populations.
Posters (3)
- Sequential Pharmacotherapy for ADHD and Comorbid DMDD: Open-Label Lisdexamfetamine Followed by Randomized Adjunctive Fluoxetine vs Placebo — Margaret Y. Yau et al.
- Medication Experience and Adherence to Methylphenidate in Children With Fetal Alcohol Spectrum Disorder: A Qualitative Study — Michel Spodenkiewicz
- ADHD Pharmacotherapy in the Context of Depression: Real-World Treatment Patterns and Clinical Outcomes Among Youth and Young Adults — Raman Baweja et al.
Thursday, October 29
09:00–11:00 · Session
Understanding and Treating Aggression in Youth With ADHD
Ekaterina Stepanova · Robert L. Findling · Joseph C. Blader · Alex S. Holdaway · Jeffrey H. Newcorn
Clinical perspectives on understanding and treating aggression in children and adolescents with ADHD.
09:00–11:00 · Lecture · Clinical Perspectives
Pharmacotherapy of Aggression in Context of ADHD
Discusses medication options for managing aggression in patients with ADHD.
10:00–12:00 · Lecture
Stimulant Treatment-Emergent Mania in Pediatric Bipolar Disorder
Looks at mania emerging during stimulant treatment in children and adolescents with bipolar disorder.
11:30–13:00 · Lecture · Research Pipeline: New Findings on Therapeutics
Impact of Centanafadine in Children and Adolescents With Severe Baseline ADHD: Pooled Subgroup Analysis of Two Phase III Clinical Trials
Caroline L. Ward · Zhen Zhang · Gregory Parks · Taisa Skubiak · Ann C. Childress
Pooled subgroup analysis of two phase III trials of centanafadine in children and adolescents with severe baseline ADHD.
14:00–17:00 · Oral abstract
Stimulant Treatment for ADHD and Long-Term Risk of Anxiety and Depression Disorders
Hila Weisblum Neuman · Sara Via Dorembus · Eyal Elron · Omer Bar Yosef
Assesses whether stimulant treatment for ADHD is associated with long-term risk of later anxiety and depression disorders.
14:30–16:30 · Lecture · Symposium
Predictors of ADHD Medication Use in Youth and Adults With Co-occurring Substance Use Disorders
Raman Baweja · Daniel A. Waschbusch · Nandini Sarkar · Ritika Baweja · Balwinder Singh · Brooke S.G. Molina · Timothy E. Wilens · James G. Waxmonsky
Explores factors associated with ADHD medication use among youth and adults who also have substance use disorders.
14:30–16:00 · Lecture
Long-Term Outcomes of Stimulant Treatment: Evidence, Limitations, and Clinical Implications
Reviews the evidence, limitations and clinical implications of long-term stimulant treatment outcomes.
14:30–16:00 · Lecture
Safety, Monitoring, and Controversies in Long-Term Stimulant Use
Covers safety, monitoring and debated issues in long-term stimulant use.
Symposium · Symposium
ADHD Treatment in the Real World: Outcomes, Comorbidities, and Clinical Decision-Making
Raman Baweja · Jeffrey H. Newcorn · Margaret D. Weiss · James G. Waxmonsky · Cesar A. Soutullo
Symposium on real-world ADHD treatment outcomes and decision-making in the presence of comorbidity, led by prominent ADHD trialists including Jeffrey Newcorn and Margaret Weiss.
Symposium · Clinical Perspectives
Do Stimulants Change the Course of ADHD? Evidence, Limits, Risks, and Next Steps
Mayank Gupta · Steven R. Pliszka · James Swanson · Nihit Gupta
A hard look at whether stimulant treatment alters the long-term trajectory of ADHD, with MTA study investigator James Swanson and treatment-guideline author Steven Pliszka.
Posters (1)
- Effects of Stimulant Treatment on Behaviors and Brain Activation Relevant to Substance Use Disorder Risk — Iliyan Ivanov et al.
Friday, October 30
09:00–12:00 · Lecture · Honors Presentations
Elaine Schlosser Lewis Award for Research on Attention-Deficit Disorder: Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ In Response to Atomoxetine
Award presentation on cognitively defined ADHD subtypes, their neural and clinical profiles, and differing atomoxetine response.
09:30–11:30 · Symposium · Clinical Perspectives
Treating ADHD in the Context of Comorbidities: Clinical Strategies Across the Spectrum
Melissa Kelley · Adelaide S. Robb · Ayman Saleh · Robyn P. Thom · Laurel Weaver · Sivabalaji Kaliamurthy
Presents clinical strategies for treating ADHD when it co-occurs with other psychiatric conditions.
09:30–11:30 · Lecture · Clinical Perspectives
Medication Management of ADHD in Pediatric Patients With Restrictive Eating Disorders
Covers medication approaches for ADHD in pediatric patients who also have restrictive eating disorders.
10:00–12:00 · Session
When Sleep, SSRIs, and Stimulants Collide: A Preadolescent Case of Psychosis, Mania, and Diagnostic Uncertainty
David J. Miklowitz · Benjamin Schneider · Kate M. Hagen · David Okikawa · Margaret Y. Yau
Clinical case conference on a 10-year-old with anxiety, ADHD and OCD who developed psychosis and then mania after SSRI and stimulant treatment. Covers diagnostic differentiation, medication risks and benefits, and culturally responsive family-centered care.
Bipolar Disorder · Child & Adolescent · Measurement-Based Care & Diagnosis
14:00–16:00 · Session · Clinical Perspectives
Perinatal ADHD Management to Promote Maternal and Infant Health: Pharmacotherapy, Nonpharmacological Strategies, and Workplace Accommodations for Physicians
Karuna S. Poddar · Misty C. Richards · Margaret Y. Yau · Lalita Thitiseranee · Sophia H. Wang · Sophia Youn
Covers managing ADHD during the perinatal period, including medication and nonmedication approaches and workplace accommodations for physicians.
14:00–16:00 · Lecture · Clinical Perspectives
Evidence-Based Pharmacotherapy for ADHD Management During the Perinatal Period
Reviews evidence on medication treatment of ADHD during pregnancy and the postpartum period.
Posters (5)
- The Exposome Predicts ADHD Medication Use Independent of Symptom Severity — Isaac Crane et al.
- Resting-State Functional Connectivity of Frontoparietal and Dorsal Attention Networks as Predictors of Methylphenidate Response in Children and Adolescents With ADHD — Yeeji Sung et al.
- A Phase 4 Safety, Tolerability, and Efficacy Study of Serdexmethylphenidate/Dexmethylphenidate in Children With ADHD — Ann C. Childress et al.
- A Systematic Review of Stimulant-Prescribing Trends in Telehealth Care for Children and Adolescents — Bisma Masudi et al.
- Decomposing Trends in ADHD Medication Use Among US Children, 2016–2024 — Amy Mahler et al.
Saturday, October 31
07:00–08:30 · Workshop
Complex ADHD in Youth: Assessment and Management Across Comorbidities and Developmental Profiles
Case-based breakfast consultation on assessing and managing youth with ADHD who also have mood, anxiety, irritability, trauma, autism or substance use concerns. Covers combined pharmacologic and psychosocial strategies adapted to developmental stage and tolerability.
ADHD · Autism & Neurodevelopmental Disorders · Child & Adolescent
10:00–12:00 · Lecture
Stimulants or Nonstimulants for ADHD: Introducing the PATH-ADHD Study
Jeffrey H. Newcorn · Stephen V. Faraone
Introduces the PATH-ADHD study comparing stimulant and nonstimulant treatment choices for ADHD.
13:00–15:00 · Session
Managing the Rise in College Students Seeking Diagnosis and Treatment of ADHD
Leah Jesse · Priya F. Gearin · Ellen House · Susan Morine
Clinical perspectives on handling the growing number of college students seeking ADHD evaluation and treatment.
Symposium · Clinical Perspectives
Individualizing Management of ADHD: Selecting, Prioritizing, and Sequencing Treatments
Mark A. Stein · Steven R. Pliszka · James G. Waxmonsky · Jeffrey H. Newcorn · Stephen V. Faraone · Margaret D. Weiss
An all-star ADHD faculty — including Stephen Faraone, Jeffrey Newcorn, Margaret Weiss, and Steven Pliszka — on how to select, prioritize, and sequence ADHD treatments for the individual patient.
Posters (2)
- Pharmacotherapy Prior to and Following Intentional Overdose Among Medicaid-Insured Adolescents With ADHD — Rachel E. Dew et al.
- Atomoxetine Augmentation for Nonsuicidal Self-Injury in Female Adolescents With Attention Problems: A Naturalistic Pre-Post Study — Kukju Kweon et al.
Other topics at this meeting
Child & Adolescent 1361Autism & Neurodevelopmental Disorders 272Diverse & Underserved Populations 231Practice, Policy & Workforce 171Psychotherapy 166Education & Training 156Digital Psychiatry & AI 149Measurement-Based Care & Diagnosis 145ADHD 135Neuroscience & Mechanisms 124PTSD & Trauma 114Suicide & Self-Harm 110